Current treatment and recent progress in gastric cancer
SS Joshi, BD Badgwell - CA: a cancer journal for clinicians, 2021 - Wiley Online Library
Gastric cancer is not a top‐10 malignancy in the United States but represents one of the
most common causes of cancer death worldwide. Biological differences between tumors …
most common causes of cancer death worldwide. Biological differences between tumors …
Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancer
S Mocellin, S Pasquali - Cochrane Database of Systematic …, 2015 - cochranelibrary.com
Background Endoscopic ultrasound (EUS) is proposed as an accurate diagnostic device for
the locoregional staging of gastric cancer, which is crucial to develo** a correct …
the locoregional staging of gastric cancer, which is crucial to develo** a correct …
The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
FH Wang, XT Zhang, YF Li, L Tang, XJ Qu… - Cancer …, 2021 - Wiley Online Library
There exist differences in the epidemiological characteristics, clinicopathological features,
tumor biological characteristics, treatment patterns, and drug selections between gastric …
tumor biological characteristics, treatment patterns, and drug selections between gastric …
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
D Cunningham, WH Allum, SP Stenning… - … England Journal of …, 2006 - Mass Medical Soc
Background A regimen of epirubicin, cisplatin, and infused fluorouracil (ECF) improves
survival among patients with incurable locally advanced or metastatic gastric …
survival among patients with incurable locally advanced or metastatic gastric …
The Neo-PLANET phase II trial of neoadjuvant camrelizumab plus concurrent chemoradiotherapy in locally advanced adenocarcinoma of stomach or …
Z Tang, Y Wang, D Liu, X Wang, C Xu, Y Yu… - Nature …, 2022 - nature.com
The synergistic effect of neoadjuvant immunotherapy and chemoradiotherapy in gastric
adenocarcinoma is unclear. This phase II trial (NCT03631615) investigated this neoadjuvant …
adenocarcinoma is unclear. This phase II trial (NCT03631615) investigated this neoadjuvant …
The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer
FH Wang, L Shen, J Li, ZW Zhou, H Liang… - Cancer …, 2019 - Springer
China is one of the countries with the highest incidence of gastric cancer. There are
differences in epidemiological characteristics, clinicopathological features, tumor biological …
differences in epidemiological characteristics, clinicopathological features, tumor biological …
Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection
SR Smalley, JK Benedetti, DG Haller… - Journal of clinical …, 2012 - ascopubs.org
Purpose Surgical resection of gastric cancer has produced suboptimal survival despite
multiple randomized trials that used postoperative chemotherapy or more aggressive …
multiple randomized trials that used postoperative chemotherapy or more aggressive …
Gastric cancer
HH Hartgrink, EPM Jansen, NCT van Grieken… - The Lancet, 2009 - thelancet.com
Gastric cancer is the second most frequent cause of cancer death worldwide, although much
geographical variation in incidence exists. Prevention and personalised treatment are …
geographical variation in incidence exists. Prevention and personalised treatment are …
TOPGEAR: a randomized, phase III trial of perioperative ECF chemotherapy with or without preoperative chemoradiation for resectable gastric cancer: interim results …
Background Postoperative chemoradiation and perioperative chemotherapy using
epirubicin/cisplatin/5-fluorouracil (ECF) represent two standards of care for resectable …
epirubicin/cisplatin/5-fluorouracil (ECF) represent two standards of care for resectable …
[HTML][HTML] Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant …
L Rubbia-Brandt, E Giostra, C Brezault, AD Roth… - Annals of oncology, 2007 - Elsevier
Background: The purpose of the study was to characterize histological response to
chemotherapy of hepatic colorectal metastases (HCRM), evaluate efficacy of different …
chemotherapy of hepatic colorectal metastases (HCRM), evaluate efficacy of different …